UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.07 +0.07 (+0.09%) GOLD FUTURES
2,311.30 +0.30 (+0.01%) DOW
38,126.84 +223.55 (+0.59%) Bitcoin GBP
47,267.18 +1,779.15 (+3.91%)
Teva Pharmaceutical Industries Limited (0LER.IL)
IOB - IOB Delayed price. Currency in USD
Add to watchlist
At close: 05:52PM BST
| Previous close | 13.93 |
| Open | 13.88 |
| Bid | 12.95 x 0 |
| Ask | 15.05 x 0 |
| Day's range | 13.80 - 14.02 |
| 52-week range | 7.10 - 14.48 |
| Volume | |
| Avg. volume | 82,045 |
| Market cap | 19.361B |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
- Thomson Reuters StreetEvents
Q1 2024 Corcept Therapeutics Inc Earnings Call
Q1 2024 Corcept Therapeutics Inc Earnings Call
- GuruFocus.com
Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
Corcept reports a robust financial performance and advances in clinical trials, despite facing potential generic competition.
© 2024 Yahoo. All rights reserved.